Metformin’s Role in Reducing Long COVID Risk for Non-Diabetic Patients
A promising treatment option for mitigating long COVID symptoms based on new research findings.
Topline:
Recent research suggests that metformin, when prescribed within a week of SARS-CoV-2 infection, can significantly reduce the risk of long COVID or death by 53% over six months in individuals without diabetes or prediabetes.
Study Details:
The study utilized data from the National COVID Cohort Collaborative (N3C) Electronic Health Record Database. …
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.